Status:
COMPLETED
Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis
Lead Sponsor:
Instituto Nacional de Cardiologia Ignacio Chavez
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a double blind randomized controlled study to evaluate the effect of aldactone on peritoneal fibrosis on incident peritoneal dialysis patients. The study would include a total of 40 incident p...
Eligibility Criteria
Inclusion
- Age \> 18
- Hospitalized for peritoneal catheter placement for peritoneal dialysis
Exclusion
- Pregnancy
- Hiperkalemia (K\> 5.5meq/l)
- Intolerance to spironolactone
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00865449
Start Date
July 1 2008
End Date
March 1 2012
Last Update
October 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional de Cardiologia Ignacio Chavez
Mexico City, Mexico City, Mexico, 14080